Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value. | Front Nutr | 2023 | 36937355 | PubTator, text mining | PubMed |
| Effects of allicin on human Simpson-Golabi-Behmel syndrome cells in mediating browning phenotype. | Front Endocrinol (Lausanne) | 2023 | 36936145 | PubTator, text mining | PubMed |
| Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. | Nat Rev Gastroenterol Hepatol | 2023 | 36932227 | PubTator, text mining | PubMed |
| Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring. | Hepatol Commun | 2023 | 36930872 | PubTator, text mining | PubMed |
| Precision nutrition in the context of bariatric surgery. | Rev Endocr Metab Disord | 2023 | 36928810 | PubTator, text mining | PubMed |
| Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes. | J Hepatocell Carcinoma | 2023 | 36926055 | PubTator, text mining | PubMed |
| Longitudinal association between overweight years, polygenic risk and NAFLD, significant fibrosis and cirrhosis. | Aliment Pharmacol Ther | 2023 | 36924053 | PubTator, text mining | PubMed |
| Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease. | Ann Transl Med | 2023 | 36923095 | PubTator, text mining | PubMed |
| Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular Diseases. | J Cardiovasc Pharmacol | 2023 | 36917556 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease - who and how? | Clin Mol Hepatol | 2023 | 36916168 | PubTator, text mining | PubMed |
| Dairy product consumption was associated with a lower likelihood of non-alcoholic fatty liver disease: A systematic review and meta-analysis. | Front Nutr | 2023 | 36908921 | PubTator, text mining | PubMed |
| Azonal steatosis correlates with disease severity and poor outcome of nonalcoholic fatty liver disease. | J Dig Dis | 2023 | 36908183 | PubTator, text mining | PubMed |
| Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different? | Clin Mol Hepatol | 2023 | 36907573 | PubTator, text mining | PubMed |
| The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases. | Nutrients | 2023 | 36904122 | PubTator, text mining | PubMed |
| TM6SF2-rs58542926 Genetic Variant Modifies the Protective Effect of a "Prudent" Dietary Pattern on Serum Triglyceride Levels. | Nutrients | 2023 | 36904112 | PubTator, text mining | PubMed |
| Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges. | Int J Mol Sci | 2023 | 36902015 | PubTator, text mining | PubMed |
Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies. | Medicine (Baltimore) | 2023 | 36897668 | PubTator, text mining | PubMed |
| Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors? | Clin Mol Hepatol | 2023 | 36891605 | PubTator, text mining | PubMed |
| The exposome and liver disease - how environmental factors affect liver health. | J Hepatol | 2023 | 36889360 | PubTator, text mining | PubMed |
| Association of PNPLA3 SNP With the Development of HBV-related Hepatocellular Carcinoma. | In Vivo | 2023 | 36881106 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=43